Published in Oncology Business Week, March 21st, 2010
"Furthermore, xanthohumol repressed proliferation and migration, as well as TNF induced NF-kappa B activity and interleukin-8 expression in both cell lines at even lower concentrations. In contrast, xanthohumol...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.